Tatva Chintan Pharma Chem has informed that the meeting of the Board of Directors of the Company is scheduled on 23/10/2021 to consider and approve the unaudited standalone financial results of the Company for the quarter and half year ended 30 September 2021; Consider and approve the unaudited consolidated financial results of the Company for the quarter and half year ended 30 September 2021.
The above information is a part of company’s filings submitted to BSE.